Biotechnology Axsome Therapeutics Announces Results of the SUPPORT Survey of Patients with Major Depressive Disorder Presented at the American Society of Clinical Psychopharmacology Association (ASCP) 2022 Annual Meeting June 6, 2022
Biotechnology Positive Phase 1 Data from mRNA-based Individualized Neoantigen Specific Immunotherapy in Patients with Resected Pancreatic Cancer presented at ASCO June 5, 2022
Biotechnology Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Oscar Health, Axsome, Humbl, and Okta and Encourages Investors to Contact the Firm June 3, 2022
Biotechnology The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of FHS, OSCR and AXSM June 3, 2022
Biotechnology AXSM Investors Have Opportunity to Lead Axsome Therapeutics, Inc. Securities Fraud Lawsuit June 3, 2022
Biotechnology Why Is Apellis Pharmaceuticals, Inc. (APLS) Down 4.5% Since Last Earnings Report? June 3, 2022
Biotechnology Why Is Allogene Therapeutics (ALLO) Down 14.9% Since Last Earnings Report? June 3, 2022
Health Deciphera Pharmaceuticals, Inc. (DCPH) Up 4.3% Since Last Earnings Report: Can It Continue? June 3, 2022
Search
investing in biotech
